ReviewJournal of personalized medicine2021

Are Parkinson's Disease Patients the Ideal Preclinical Population for Alzheimer's Disease Therapeutics?

Thomas F Tropea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.